TL;DR CNBC

Keyword: eisai co ltd

2024-09-09 07:52:59 5 things to know before the stock market opens Monday MIXED 4523.T-JP, TSLA, .DJI, BA, .IXIC, .SPX, F, RIVN, NSC, GM,	2024-09-08 08:00:01 Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment MIXED BIIB, 4523.T-JP, ESALY,	2024-04-24 10:26:32 Biogen tops profit estimates as cost cuts take hold, Alzheimer's drug Leqembi launch picks up POSITIVE ESALY, 4523.T-JP, BIIB,	2024-03-08 11:22:29 Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move MIXED BIIB, LLY, 4523.T-JP,
2024-02-20 14:15:29 Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start MIXED BIIB, 4523.T-JP, ESALY,	2024-02-13 10:40:34 Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies NEGATIVE 4523.T-JP, SAGE, BIIB, ESALY,	2024-01-31 12:24:53 Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments MIXED BIIB, 4523.T-JP,	2023-12-20 07:00:01 Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma MIXED 4523.T-JP, JNJ, PFE, BMY, MRK, AZN-GB, LLY, AMGN, NOVO.B-DK, BIIB,
2023-12-02 08:00:01 Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops NEGATIVE 4523.T-JP, PFE, ABT, NOVO.B-DK, LLY, SAN-FR,	2023-07-08 07:00:01 Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know MIXED 4523.T-JP, BIIB,	2023-07-07 14:11:51 Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024 MIXED 4523.T-JP, BIIB,	2023-07-07 08:14:50 Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug MIXED 4523.T-JP, BIIB,
2023-05-01 11:28:30 Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments POSITIVE 4523.T-JP, BIIB,	2023-04-25 13:56:40 Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says NEUTRAL ESALY, BIIB, 4523.T-JP, LLY,	2023-03-13 18:40:54 Veterans Health Administration will cover Alzheimer's treatment Leqembi, Eisai says NEUTRAL ESALY, 4523.T-JP, BIIB,	2023-03-06 10:45:23 FDA will review Eisai and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July MIXED EII-FF, BIIB, 4523.T-JP,
2023-02-23 12:33:51 Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi NEGATIVE 4523.T-JP, ESALY, BIIB,	2023-02-17 15:25:35 Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows POSITIVE BIIB, 4523.T-JP, ESALY,	2023-02-17 10:29:11 Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage POSITIVE BIIB, 4523.T-JP, ESALY,	2023-01-06 19:10:09 FDA approves Alzheimer's drug that slowed cognitive decline in clinical trial NEUTRAL 4523.T-JP, BIIB,

Found 20 articles